Advanced search
Publication Cover
Leukemia & Lymphoma Volume 51, 2010 - Issue 7
Submit an article Journal homepage
248
Views
18
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Expression profiles of adult T-cell leukemia–lymphoma and associations with clinical responses to zidovudine and interferon α

Ash A. AlizadehDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
,
Sean P. BohenDivision of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA
,
Chen LossosDivision of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA
,
Jose A. Martinez-ClimentDivision of Oncology, Center for Applied Medical Research, University of Navarra, Pamplona, Spain
,
Juan Carlos RamosDivision of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA
,
Elena Cubedo-GilDivision of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA
,
William J. Harrington Jr.Division of Hematology-Oncology, Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, Florida, USA
&
Izidore S. LossosCorrespondence[email protected]
 show all
Pages 1200-1216 | Received 25 Jan 2010, Accepted 23 Feb 2010, Published online: 07 Apr 2010

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Morie A. Gertz & Tamar Tadmor. (2010) Individualizing cancer therapy. Leukemia & Lymphoma 51:9, pages 1585-1587.
Read now
Elena M. Hartmann & Andreas Rosenwald. (2010) Gene expression signatures of adult T-cell leukemia: is treatment response prediction on the horizon?. Leukemia & Lymphoma 51:7, pages 1157-1158.
Read now

Articles from other publishers (16)

Tyler A. Herek & Javeed Iqbal. 2021. The Peripheral T‐Cell Lymphomas. The Peripheral T‐Cell Lymphomas 91 103 .
Lucy B. Cook, Shigeo Fuji, Olivier Hermine, Ali Bazarbachi, Juan Carlos Ramos, Lee Ratner, Steve Horwitz, Paul Fields, Alina Tanase, Horia Bumbea, Kate Cwynarski, Graham Taylor, Thomas A. Waldmann, Achilea Bittencourt, Ambroise Marcais, Felipe Suarez, David Sibon, Adrienne Phillips, Matthew Lunning, Reza Farid, Yoshitaka Imaizumi, Ilseung Choi, Takashi Ishida, Kenji Ishitsuka, Takuya Fukushima, Kaoru Uchimaru, Akifumi Takaori-Kondo, Yoshiki Tokura, Atae Utsunomiya, Masao Matsuoka, Kunihiro Tsukasaki & Toshiki Watanabe. (2019) Revised Adult T-Cell Leukemia-Lymphoma International Consensus Meeting Report. Journal of Clinical Oncology 37:8, pages 677-687.
Crossref
Javeed Iqbal & Laurence de Leval. 2019. Lexikon der Medizinischen Laboratoriumsdiagnostik. Lexikon der Medizinischen Laboratoriumsdiagnostik 95 141 .
Mathew A. Cherian, Sydney Olson, Hemalatha Sundaramoorthi, Kitra Cates, Xiaogang Cheng, John Harding, Andrew Martens, Grant A. Challen, Manoj Tyagi, Lee Ratner & Daniel Rauch. (2018) An activating mutation of interferon regulatory factor 4 (IRF4) in adult T-cell leukemia. Journal of Biological Chemistry 293:18, pages 6844-6858.
Crossref
Pengru Huang, Yujie Cai, Bin Zhao & Lili Cui. (2018) Roles of NUCKS1 in Diseases: Susceptibility, Potential Biomarker, and Regulatory Mechanisms. BioMed Research International 2018, pages 1-7.
Crossref
T Dierckx, R Khouri, S M Menezes, D Decanine, L Farre, A Bittencourt, A M Vandamme & J Van Weyenbergh. (2017) IFN-β induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-α in PBMCs of Adult T-cell Leukemia/Lymphoma patients. Blood Cancer Journal 7:1, pages e519-e519.
Crossref
Yangbo Yue, Stanley G. Leung, Yueyong Liu, Yurong Huang, Kirsten Grundt, Anne-Carine Østvold, Kuang-Yu Jen, David Schild, Jian-Hua Mao & Claudia Wiese. (2016) Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice . Oncotarget 7:38, pages 61874-61889.
Crossref
Emma M.C. Driessen, Sandra S. Mimoso Pinhanços, Pauline Schneider, Paola de Lorenzo, Maria G. Valsecchi, Rob Pieters & Ronald W. Stam. (2016) Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia. European Journal of Cancer 57, pages 87-90.
Crossref
. 2016. Diagnostic Pathology: Molecular Oncology. Diagnostic Pathology: Molecular Oncology 6-112 6-117 .
K Fujii, M B Karpova, K Asagoe, O Georgiev, R Dummer & M Urosevic-Maiwald. (2015) Versican upregulation in Sézary cells alters growth, motility and resistance to chemotherapy. Leukemia 29:10, pages 2024-2032.
Crossref
Alexander J. A. DeutschBeate RinnerKerstin WenzlMartin Pichler, Katharina TroppanElisabeth SteinbauerDaniela Schwarzenbacher, Sonja ReitterJulia FeichtingerSascha TierlingAndreas ProkeschMarcel ScheidelerAnne Krogsdam, Gerhard G. ThallingerHelmut Schaider, Christine Beham-SchmidPeter Neumeister. (2014) NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas. Blood 123:15, pages 2367-2377.
Crossref
Jay L Patel, Payam Pournazari, Sarah-Joy Haggstrom, Farid Kosari, Meer-Taher Shabani-Rad, Yasodha Natkunam & Adnan Mansoor. (2014) LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype. Histopathology 64:2, pages 226-233.
Crossref
Roberto N. Miranda, Joseph D. Khoury & L. Jeffrey MedeirosRoberto N. Miranda, Joseph D. Khoury & L. Jeffrey Medeiros. 2013. Atlas of Lymph Node Pathology. Atlas of Lymph Node Pathology 341 345 .
Paul A. Fields & Graham P. Taylor. (2012) ?Antivirals? in the Treatment of Adult T Cell Leukaemia? Lymphoma (ATLL). Current Hematologic Malignancy Reports 7:4, pages 267-275.
Crossref
Juan Carlos Ramos & Izidore S. Lossos. (2011) Newly Emerging Therapies Targeting Viral-Related Lymphomas. Current Oncology Reports 13:5, pages 416-426.
Crossref
S Ning, J S Pagano & G N Barber. (2011) IRF7: activation, regulation, modification and function. Genes & Immunity 12:6, pages 399-414.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.